These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 17328268)
41. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas. Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843 [TBL] [Abstract][Full Text] [Related]
42. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis. Marks RA; Zhang S; Montironi R; McCarthy RP; MacLennan GT; Lopez-Beltran A; Jiang Z; Zhou H; Zheng S; Davidson DD; Baldridge LA; Cheng L Prostate; 2008 Jun; 68(9):919-23. PubMed ID: 18409189 [TBL] [Abstract][Full Text] [Related]
43. EGFR gene and protein expression in breast cancers. Park K; Han S; Shin E; Kim HJ; Kim JY Eur J Surg Oncol; 2007 Oct; 33(8):956-60. PubMed ID: 17374474 [TBL] [Abstract][Full Text] [Related]
44. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma. Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063 [TBL] [Abstract][Full Text] [Related]
45. DNA topoisomerase IIalpha and Her-2/neu gene dosages in pediatric malignant gliomas. Bredel C; Lassmann S; Pollack IF; Knoth R; Hamilton RL; Volk B; Werner M; Bredel M Int J Oncol; 2005 May; 26(5):1187-92. PubMed ID: 15809708 [TBL] [Abstract][Full Text] [Related]
46. The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years. Korshunov A; Sycheva R; Golanov A Cancer; 2005 Aug; 104(4):825-32. PubMed ID: 15981281 [TBL] [Abstract][Full Text] [Related]
47. Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group. Pollack IF; Hamilton RL; Burger PC; Brat DJ; Rosenblum MK; Murdoch GH; Nikiforova MN; Holmes EJ; Zhou T; Cohen KJ; Jakacki RI; J Neurooncol; 2010 Sep; 99(2):155-63. PubMed ID: 20607350 [TBL] [Abstract][Full Text] [Related]
48. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome. Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002 [TBL] [Abstract][Full Text] [Related]
49. Molecular abnormalities in pediatric embryonal brain tumors--analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22. Zakrzewska M; Rieske P; Debiec-Rychter M; Zakrzewski K; Polis L; Fiks T; Liberski PP Clin Neuropathol; 2004; 23(5):209-17. PubMed ID: 15581023 [TBL] [Abstract][Full Text] [Related]
50. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770 [TBL] [Abstract][Full Text] [Related]
51. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757 [TBL] [Abstract][Full Text] [Related]
52. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization. Dancer J; Takei H; Ro JY; Lowery-Nordberg M Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361 [TBL] [Abstract][Full Text] [Related]
53. Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort. Pollack IF; Finkelstein SD; Burnham J; Hamilton RL; Yates AJ; Holmes EJ; Boyett JM; Finlay JL Pediatr Neurosurg; 2003 Sep; 39(3):114-21. PubMed ID: 12876389 [TBL] [Abstract][Full Text] [Related]
54. [Towards a molecular classification of gliomas]. Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387 [TBL] [Abstract][Full Text] [Related]
55. Epidermal growth factor receptor is not amplified in schwannomas. Prayson RA; Yoder BJ; Barnett GH Ann Diagn Pathol; 2007 Oct; 11(5):326-9. PubMed ID: 17870017 [TBL] [Abstract][Full Text] [Related]
56. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Yatabe Y; Takahashi T; Mitsudomi T Cancer Res; 2008 Apr; 68(7):2106-11. PubMed ID: 18381415 [TBL] [Abstract][Full Text] [Related]
57. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion. Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715 [TBL] [Abstract][Full Text] [Related]
59. Shared molecular targets in pediatric gliomas and ependymomas. Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772 [TBL] [Abstract][Full Text] [Related]
60. EGFR intragenic loss and gene amplification in astrocytic gliomas. Arjona D; Bello MJ; Rey JA Cancer Genet Cytogenet; 2006 Jan; 164(1):39-43. PubMed ID: 16364761 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]